SRAM
AMED

Stone Ridge Asset Management’s Amedisys AMED Stock Holding History

Stone Ridge Asset Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,657
Closed -$528K – 21
2020
Q2 		$528K Sell
2,657
-9,630
-78% -$1.8M 0.08% 261
2020
Q1 		$2.25M Hold
12,287
– – 0.24% 60
2019
Q4 		$2.05M Hold
12,287
– – 0.12% 196
2019
Q3 		$1.61M Hold
12,287
– – 0.1% 257
2019
Q2 		$1.49M Sell
12,287
-600
-5% -$71.2K 0.09% 273
2019
Q1 		$1.59M Buy
12,887
+100
+0.8% +$12.6K 0.09% 273
2018
Q4 		$1.5M Buy
12,787
+1,203
+10% +$142K 0.09% 263
2018
Q3 		$1.45M Buy
11,584
+3,193
+38% +$353K 0.08% 298
2018
Q2 		$717K Buy
8,391
+1,476
+21% +$108K 0.04% 601
2018
Q1 		$417K Hold
6,915
– – 0.02% 878
2017
Q4 		$364K Buy
+6,915
New +$364K 0.02% 965

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Stone Ridge Asset Management's AMED Position: Q3 2020 in Review

Stone Ridge Asset Management sold out of Amedisys (AMED) in Q3 2020, closing a stake of 2,657 shares — an estimated $528K sold.

Stone Ridge Asset Management first reported a position in AMED in Q4 2017 and held it in 11 quarters. The position peaked at $2.25M in Q1 2020. 397 funds tracked by Wall St. Rank hold AMED as of Q3 2020.

  • Stone Ridge Asset Management reported no remaining Amedisys position as of Q3 2020 after selling out during the quarter.
  • Stone Ridge Asset Management sold 2,657 Amedisys shares in Q3 2020, an estimated $528K.
  • Stone Ridge Asset Management first reported a position in Amedisys in Q4 2017 and held it in 11 quarters.
  • Stone Ridge Asset Management's Amedisys position peaked at $2.25M in Q1 2020.
  • 397 funds tracked by Wall St. Rank held Amedisys as of Q3 2020.

Based on Stone Ridge Asset Management's 13F filing for Q3 2020.